MARA Notice: Insider RSU Vesting and Proposed 34,732-Share Sale
Rhea-AI Filing Summary
Form 144 notice for proposed sale of common stock. The filer proposes to sell 34,732 common shares through Fidelity Brokerage Services on 08/15/2025 on NASDAQ with an aggregate market value of $546,334.36. The filing reports 370,457,880 shares outstanding. Acquisition detail for the shares sold shows they were granted as restricted stock vesting on 07/31/2024 (1,333 shares), 10/01/2024 (9,163 shares) and 10/31/2024 (24,236 shares) and paid as compensation. The filing also lists three sales by The S&N Khan Family Trust in the past three months: 16,700 shares on 05/16/2025 for $261,856.00, 34,733 shares on 06/12/2025 for $550,518.05, and 34,732 shares on 07/15/2025 for $661,644.60. Certain issuer identification fields and signature/notice dates are not populated in the provided content.
Positive
- Transaction details provided: broker, proposed sale date, share counts and aggregate market value are disclosed
- Acquisition source clear: shares originated from restricted stock vesting and were paid as compensation
- Recent sale history disclosed: three transactions with dates, amounts and gross proceeds included
Negative
- Issuer identification fields not populated in the provided extract, limiting direct issuer linkage within the form content
- Remarks/signature/date fields absent in the supplied content, reducing administrative completeness of the notice
Insights
TL;DR: Routine insider/beneficiary sales and RSU vesting reported; transaction sizes are small relative to outstanding shares.
The filing documents a proposed single-day sale of 34,732 common shares valued at $546,334.36 and shows recent related sales totaling 83,165 shares over three months. Acquisition entries indicate these shares arose from restricted stock vesting and were compensation-related. Against an outstanding share base of 370,457,880, the proposed sale and recent sales represent a de minimis percentage of shares outstanding. The filing is procedural and provides clear trade counterpart/broker details for the proposed sale.
TL;DR: Disclosure format largely complete but several form fields appear blank, reducing transparency.
The notice identifies broker, proposed sale date, quantities, values and acquisition basis (restricted stock vesting), which aligns with Rule 144 disclosure practice. However, key issuer identification and signature/notice dates are not present in the supplied content, and the filing includes an explicit representation checkbox text but no populated execution details. From a compliance standpoint, the substantive trade data is present but administrative omissions in the provided extract should be resolved to ensure full traceability and regulatory completeness.